Natera Announces New Publication Validating Signatera® Velocity Metric to Improve Cancer Management
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA testing, today announced the publication of a new...